From: Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
Characteristic | All patient-partner pairs+ (N = 198) | ||
---|---|---|---|
Concordant positive (N = 19) | Concordant negative (N = 159) | p-value* | |
Patient age, years | |||
< 55 | 7 (36.8 %) | 69 (43.4 %) | .59 |
≥ 55 | 12 (63.2 %) | 90 (56.6 %) | |
Partner age, years | |||
< 55 | 6 (31.6 %) | 91 (57.6 %) | .03 |
≥ 55 | 13 (68.4 %) | 67 (42.4 %) | |
Patient sex | |||
F | 4 (21.1 %) | 32 (20.1 %) | 1.0 |
M | 15 (78.9 %) | 127 (79.9 %) | |
Partner sex | |||
F | 15 (78.9 %) | 127 (79.9 %) | 1.0 |
M | 4 (21.1 %) | 32 (20.1 %) | |
Patient race | |||
White | 13 (68.4 %) | 146 (91.8 %) | .002 |
Other | 6 (31.6 %) | 13 (8.2 %) | |
Partner race | |||
White | 13 (68.4 %) | 125 (78.6 %) | .31 |
Other | 6 (31.6 %) | 34 (21.4 %) | |
Patient smoking status | |||
Former/never | 8 (61.5 %) | 76 (71.7 %) | .52 |
Current | 5 (38.5 %) | 30 (28.3 %) | |
Partner smoking status | |||
Former/never | 7 (53.8 %) | 58 (66.7 %) | .37 |
Current | 6 (46.2 %) | 29 (33.3 %) | |
Patient history of benign HPV disease | |||
None | 19 (100 %) | 154 (96.9 %) | 1.0 |
Yes | 0 (0 %) | 5 (3.1 %) | |
Partner history of benign HPV disease | |||
None | 19(100 %) | 153 (96.2 %) | 1.0 |
Yes | 0 (0 %) | 6 (3.8 %) | |
Patient history of HPV cancer | |||
None | 18 (94.7 %) | 155 (97.5 %) | .44 |
Yes | 1 (5.3 %) | 4 (2.5 %) | |
Partner history of HPV cancer | |||
None | 19 (100 %) | 155 (97.5 %) | 1.0 |
Yes | 0 (0 %) | 4 (2.5 %) |